Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on May 14, 2026

Lexicon & Line Awarded Federal Contract Supporting DEA Community Outreach Initiative
The Home as Healthcare’s Next Frontier: New Research Defines the Therapeutic Home for Chronic Conditions like Migraine
Lumea Named Best New Biopsy Technology Solution in 2026 Medtech Breakthrough Awards
BioSyent Declares Second Quarter 2026 Dividend
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
BioSyent Releases Financial Results for First Quarter 2026
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update
Nuo Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum
Precipio Announces Q1 2026 Financial Results
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
HEALIOS K.K. to Present at Jefferies Global Healthcare Conference
Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes
HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results
Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update

Share this page:

Sign up for:

Healthcare Times Utah

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.